Modalità di iscrizione

L’iscrizione è gratuita e dovrà essere effettuata mediante l’invio dell’apposita scheda di registrazione, alla segreteria Organizzativa tramite fax allo 030 2097582 oppure direttamente on-line sul questo sito.

L’iscrizione comprende la partecipazione ai lavori, il kit congressuale e l’attestato di partecipazione.

 

ECM

E’ stato richiesto l’accreditamento presso la Commissione ECM del Ministero della Salute per la figura dell'Infermiere, del Medico Chirurgo, tutte le discipline, e del Biologo.

 

PROGRAM

 

8.30                Registration of the participants

 

9.00                Welcome Remarks

                        Francesco Carpani Glisenti

                        Authorities

 

                        Introduction

                        Giuseppe Rossi

 

First session: Pathology

Chair: Fabio Facchetti

 

9:30                T-cell Lymphoma: old and new classifications

Stefano Pileri

 

10.00              Normal counterparts of nodal T cell lymphoma

                        Hans Konrad Muller-Hermelink, Eva Geissinger

 

10:30              Immunophenotype: Differential diagnosis, stratification and clinical prediction

                        Maria S. Rodriguez-Pinilla

 

11:00              Coffee break          

 

 

Second session: Biology

Chair: Silvano Sozzani

 

11:15              Definition of Anaplastic Large Cell Lymphoma: old and new Entities?

                        Christiane De-Wolf-Peeters

 

11:45              Gene expression profiling of Peripheral T-Cell Lymphoma

                        Pier Paolo Piccaluga

 

12:15              Anaplastic lymphoma kinase: a new target molecule

                        Giorgio Inghirami

 

12.45              Discussion

 

 

13:00              LUNCH

 

 

Third session: Clinical

Chair: Gianpietro Semenzato

 

14.30                            Prognostic factors in PTCL 

José Rodriguez

 

15.00              Long-term follow-up of CHOP-alemtuzumab pilot study

                        Andrea Gallamini

 

15.30              CHOP and  high dose alemtuzumab protocol
Francesco D’Amore 

 

16.00              Coffee break

 

 

Fourth session: Clinical 

Chair: Domenico Russo

 

16.15             Current analysis on T-cell lymphomas treated within protocols of German NHL study group

Norbert Schmitz

 

16.45              Allogeneic transplantation and GITMO prospective  study in PTCL
Paolo Corradini

 

17.15              New drugs in PTCL

                        Pierluigi Zinzani

 

17.45                            General discussion and future prospects

Fabio Facchetti, Giorgio Inghirami, Paolo Corradini and speakers

 

18.30                           Close

Giuseppe Rossi

 

 

Scientific Committee

 

Prof. Paolo Corradini

Prof. Fabio Facchetti

Prof. Giorgio Inghirami

Dr. Giuseppe Rossi

 

---